Submitted by Anonymous (not verified) on 4 December 2025 - 15:08
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 69, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 69, Status: Authorised